Medicare HBOT Billing: What Clinics Can and Can't Charge

Q: Does Medicare require UHMS accreditation for HBOT clinics?

Medicare does not explicitly *require* UHMS accreditation for HBOT clinics to receive reimbursement. However, the FDA recommends UHMS-accredited hyperbaric facilities for treating specific illnesses, which indirectly underscores the value of accreditation. UHMS accreditation signifies that a clinic meets high standards for equipment, staff competency, and clinical protocols, which can enhance a clinic's credibility and potentially streamline the Medicare billing process due to demonstrated quali

Last updated: April 2026

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before starting any treatment.

Affiliate Disclosure: We may earn a commission when you purchase through our links. This does not affect our editorial independence.

Quick Answer

Medicare covers Hyperbaric Oxygen Therapy (HBOT) for conditions recognized by the Undersea & Hyperbaric Medical Society (UHMS), which published its 14th edition of indications in 2020.
The UHMS lists 14 primary indications for HBOT, including air or gas embolism and carbon monoxide poisoning.
The FDA recommends UHMS-accredited facilities for treating specific illnesses with HBOT.
Gas embolism from diving can occur with an ascent of as little as one meter after breathing compressed gas.

Medicare provides coverage for Hyperbaric Oxygen Therapy (HBOT) when it addresses specific medical conditions that have been officially recognized and validated by leading medical authorities. The Undersea & Hyperbaric Medical Society (UHMS) plays a central role in defining these covered conditions, having released its "Hyperbaric Oxygen Therapy Indications" in a 14th edition. This comprehensive document outlines 14 primary indications where HBOT is considered an appropriate and effective treatment. These indications range from acute, life-threatening emergencies like air or gas embolism to more chronic conditions such as selected problem wounds. In our analysis, understanding these guidelines is crucial for both patients seeking treatment and clinics managing their billing practices. The FDA also supports this framework by recommending UHMS-accredited facilities for the treatment of specific illnesses, reinforcing the importance of adherence to established standards. For instance, gas embolism, a condition where gas bubbles enter the bloodstream, is a key indication. This can occur in divers from pulmonary barotrauma after an ascent of as little as one meter following compressed gas breathing.

What Conditions Does Medicare Cover for HBOT?

Medicare generally covers Hyperbaric Oxygen Therapy (HBOT) for specific medical conditions that are well-established and supported by clinical evidence. These covered conditions are typically those recognized and endorsed by authoritative medical organizations, such as the Undersea & Hyperbaric Medical Society (UHMS). The UHMS is a key body that evaluates and publishes a comprehensive list of approved indications for HBOT, guiding both clinical practice and insurance coverage decisions.

The UHMS has a long-standing history of defining the appropriate applications for HBOT. Its "Hyperbaric Oxygen Therapy Indications" document, now in its 14th edition, serves as a cornerstone for understanding which conditions qualify for treatment. This document provides detailed information on each indication, including the rationale for HBOT use and supporting research. Prior editions, such as the 13th edition, also clearly listed Air or Gas Embolism as the first primary indication, highlighting its critical importance and established role in hyperbaric medicine. The consistent inclusion of specific conditions across multiple editions of this authoritative publication underscores their recognized medical necessity.

The Role of UHMS in Defining Coverage

The Undersea & Hyperbaric Medical Society (UHMS) is a non-profit organization dedicated to advancing undersea and hyperbaric medicine. Its "Hyperbaric Oxygen Therapy Indications" document is widely referenced by healthcare providers and payers, including Medicare, to determine the medical necessity of HBOT. This document is a product of extensive review by a committee of experts in the field. The 14th edition, published in 2020, represents the most current consensus on approved uses for hyperbaric oxygen.

For a condition to be considered for Medicare coverage, it typically needs to align with the indications listed by the UHMS. This ensures that HBOT is used for conditions where its efficacy is recognized and supported by medical evidence. The meticulous process of adding new indications, as outlined in the UHMS reference material, involves a thorough review and acceptance procedure. This structured approach helps maintain the integrity and evidence-based nature of HBOT applications. Our analysis shows that clinics seeking Medicare reimbursement must ensure that the patient's diagnosis precisely matches one of these approved indications. Without this alignment, the chances of successful billing and reimbursement significantly decrease. The UHMS, headquartered at 631 US Highway 1, Suite 307, North Palm Beach, FL 33408, USA, serves as the central authority for these guidelines.

Understanding Medical Necessity

Medical necessity is a critical concept in Medicare billing for HBOT. It means that the treatment must be appropriate and necessary for the diagnosis and treatment of an illness or injury. Simply having a hyperbaric chamber available does not automatically qualify all treatments for coverage. The patient's condition must fall within the UHMS-approved indications, and the treatment plan must adhere to established protocols for that specific indication.

For example, if a patient presents with a problem wound, the wound must meet specific criteria, such as being refractory to conventional treatment, for HBOT to be considered medically necessary and therefore covered. The UHMS document details these criteria for each indication, providing a roadmap for clinicians to follow. This detailed guidance helps prevent the misuse of HBOT and ensures that resources are directed towards patients who will genuinely benefit from the therapy. Clinics must meticulously document the patient's diagnosis, the failure of conventional treatments if applicable, and the specific parameters of the HBOT sessions to justify medical necessity for Medicare claims. The 13th edition of the Hyperbaric Oxygen Therapy Indications, edited by Lindell K. Weaver MD, Chair and Editor, emphasizes the importance of independent verification of diagnoses and drug dosages due to rapid advances in medical sciences.

Distinguishing Approved from Unapproved Uses

It is essential for clinics to differentiate between UHMS-approved indications and other conditions for which HBOT might be promoted but lack sufficient evidence for Medicare coverage. Treating conditions not on the UHMS list typically means that Medicare will not reimburse for those services. This distinction is vital for financial viability and compliance. The FDA also plays a role by recommending UHMS-accredited hyperbaric facilities for treating specific illnesses, reinforcing the importance of adhering to recognized standards. This recommendation highlights the synergy between regulatory bodies and medical societies in ensuring safe and effective healthcare.

The UHMS continually reviews scientific literature to update its list of indications. This dynamic process means that while some conditions might gain approval in the future, clinics must always refer to the current edition of the "Hyperbaric Oxygen Therapy Indications" to ensure compliance. Operating outside these established guidelines can lead to claim denials, audits, and potential penalties. Therefore, staying informed about the latest UHMS publications and FDA recommendations is not just good practice, but a necessity for any HBOT clinic engaged in Medicare billing.

What Are the UHMS Approved Indications for HBOT?

The Undersea & Hyperbaric Medical Society (UHMS) provides a comprehensive and authoritative list of approved indications for Hyperbaric Oxygen Therapy (HBOT). These indications are critical for guiding treatment protocols, ensuring patient safety, and establishing a basis for billing and reimbursement, especially for programs like Medicare. The UHMS list serves as a benchmark for what is considered medically appropriate and evidence-based use of HBOT.

The 14th edition of the UHMS "Hyperbaric Oxygen Therapy Indications" outlines 14 primary conditions for which HBOT is recommended. This extensive list covers a range of medical situations, from acute emergencies to chronic conditions that have proven difficult to treat with conventional methods. These indications are developed through rigorous scientific review by the UHMS Hyperbaric Oxygen Therapy Committee, ensuring that each recommendation is supported by medical evidence. When we compare the 13th and 14th editions, we see consistent emphasis on these critical areas of treatment.

The 14 Primary UHMS Indications

The 14th edition of the UHMS "Hyperbaric Oxygen Therapy Indications" details the following primary conditions where HBOT is considered beneficial and medically indicated:

Air or Gas Embolism: This condition involves gas bubbles entering arteries or veins, leading to blockages and tissue damage. Richard E. Moon describes arterial gas embolism (AGE) as classically occurring during submarine escape training due to pulmonary barotrauma during free ascent after breathing compressed gas at depth. Pulmonary barotrauma and gas embolism from breath holding can happen after an ascent of as little as one meter.
Arterial Insufficiencies: This category includes conditions where blood flow through arteries is inadequate.
- Central Retinal Artery Occlusion: A blockage in the main artery supplying blood to the retina, which can cause sudden vision loss.
- Hyperbaric Oxygen Therapy for Selected Problem Wounds: This refers to chronic, non-healing wounds that have not responded to standard treatments.
Carbon Monoxide Poisoning: A toxic condition resulting from inhaling carbon monoxide, which reduces the blood's ability to carry oxygen.
Clostridial Myonecrosis (Gas Gangrene): A severe bacterial infection that produces gas within tissues, leading to rapid tissue destruction.
The Effect of Hyperbaric Oxygen on Compromised Grafts and Flaps: HBOT can improve the survival of transplanted tissues (grafts) and sections of skin or tissue moved from one part of the body to another (flaps) that are at risk of failing due to poor blood supply.
The Role of Hyperbaric Oxygen for Acute Traumatic Ischemias: This covers sudden, severe reductions in blood flow to tissues due to trauma, such as crush injuries.
Decompression Sickness: A condition affecting divers when dissolved gases come out of solution in the blood and tissues as bubbles during ascent.
Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) and Potential for Future Research: Damage to tissues and bones that appears months or years after radiation therapy.
Sudden Sensorineural Hearing Loss: A rapid, unexplained loss of hearing, often affecting one ear.
Intracranial Abscess: A collection of pus within the brain.
Necrotizing Soft Tissue Infections: Severe infections that cause rapid death of soft tissues, including muscles, fascia, and fat.
Refractory Osteomyelitis: A persistent bone infection that has not responded to conventional antibiotic treatment or surgery.
Severe Anemia: A condition where the blood lacks healthy red blood cells to carry adequate oxygen to the body's tissues, and transfusions are impossible or ineffective.
Adjunctive Hyperbaric Oxygen Therapy in the Treatment of Thermal Burns: HBOT used in addition to standard burn care to promote healing and reduce complications.

These indications are thoroughly discussed in the UHMS document, providing detailed criteria for diagnosis and treatment protocols. Clinics must ensure that a patient's condition aligns precisely with these definitions to meet medical necessity requirements for billing. UHMS Hyperbaric Oxygen Therapy Indications (14th Edition) serves as the primary reference for these guidelines.

Importance for Billing and Clinic Operations

For hyperbaric clinics, understanding and strictly adhering to this list is paramount for successful Medicare billing. Each indication has specific diagnostic codes and treatment parameters that must be followed. Failure to accurately document the diagnosis, the medical necessity, and the treatment plan in accordance with UHMS guidelines can lead to claim denials.

The UHMS document not only lists the indications but also provides background information and utilization review considerations for HBOT. This includes defining hyperbaric oxygen therapy itself, which refers to the medical use of oxygen at an ambient pressure higher than atmospheric pressure. This definition is fundamental to understanding the therapy and its applications. We find that meticulous record-keeping, aligning patient charts with UHMS criteria, and staying updated with the latest edition of the indications are non-negotiable for clinics aiming for compliant and successful billing.

Evolution of UHMS Indications

The UHMS regularly updates its "Hyperbaric Oxygen Therapy Indications" to reflect new scientific evidence and clinical experience. For example, the 13th edition, published earlier, also listed Air or Gas Embolism as the first indication, followed by Arterial Insufficiencies, Carbon Monoxide Poisoning, Clostridial Myonecrosis (Gas Gangrene), and Compromised Grafts and Flaps. This continuous review process ensures that the guidelines remain current and relevant. See the gas gangrene evidence atlas for the full study-by-study evidence breakdown.

Clinics should regularly consult the latest UHMS publications to ensure they are operating with the most up-to-date information. This commitment to evidence-based practice not only supports proper billing but also upholds the highest standards of patient care. The UHMS is recognized as a leader in hyperbaric medicine, and its recommendations carry significant weight within the medical community and with insurance providers.

How Does Gas Embolism Relate to HBOT Coverage?

Gas embolism is a critical and well-established indication for Hyperbaric Oxygen Therapy (HBOT), and its treatment is typically covered by Medicare when diagnosed appropriately. This condition involves gas bubbles entering the circulatory system, which can lead to severe and life-threatening blockages. HBOT is uniquely effective in treating gas embolism because it can reduce the size of these bubbles and improve oxygen delivery to tissues starved of blood flow.

Gas embolism can arise from a variety of sources, not exclusively from diving incidents. While often associated with underwater activities, the mechanisms of gas entry into the bloodstream are diverse. Richard E. Moon, in "Hyperbaric Oxygen Therapy Indications: Air or Gas Embolism," explains that gas embolism occurs when gas bubbles enter arteries or veins. He further clarifies that arterial gas embolism (AGE) was initially described in contexts like submarine escape training, where pulmonary barotrauma could result from a free ascent after breathing compressed gas at depth. Importantly, pulmonary barotrauma and subsequent gas embolism from breath holding can occur after an ascent of as little as one meter. This highlights that even relatively minor pressure changes can trigger the condition.

Causes of Gas Embolism Beyond Diving

While diving is a known cause, gas embolism can also result from a wide array of medical procedures and traumatic events. The research outlines numerous other causes for both arterial gas embolism (AGE) and venous gas embolism (VGE).

Causes of AGE and VGE include:

Pulmonary Barotrauma: This can occur from blast injury (in or out of water), mechanical ventilation, penetrating chest trauma, chest tube placement, and bronchoscopy. It can also happen in divers with underlying lung conditions like bullous disease and asthma, even during normal ascent.
Accidental Intravenous Air Injection: This can occur during various medical interventions.
Cardiopulmonary Bypass Accidents: Complications during heart-lung machine use.
Needle Biopsy of the Lung: A procedure where a tissue sample is taken from the lung.
Hemodialysis: A treatment for kidney failure.
Central Venous Catheter Placement or Disconnection: Issues with catheters inserted into large veins.
Gastrointestinal Endoscopy: Procedures involving inserting a scope into the digestive tract.
Hydrogen Peroxide Irrigation or Ingestion: Use or consumption of hydrogen peroxide.
Arthroscopy: A minimally invasive joint surgery.
Cardiopulmonary Resuscitation (CPR): Air can enter the circulation during chest compressions.
Percutaneous Hepatic Puncture: A procedure involving the liver.
Orogenital Sex: Blowing air into the vagina during sex.
Sexual Intercourse After Childbirth: Can introduce air into the venous system.
Surgical Procedures with Pressurized Sites: Examples include laparoscopy, transurethral surgery, vitrectomy, endoscopic vein harvesting, and hysteroscopy.
Passive Entry of Air into Surgical Wounds: This can happen when surgical sites are elevated above the heart, creating subatmospheric pressure in adjacent veins. This has been described in sitting craniotomy, cesarean section, prostatectomy (radical perineal and retropubic approaches), spine surgery, hip replacement, liver resection, liver transplantation, and dental implant insertion.

This extensive list demonstrates that gas embolism is a broad clinical problem, making HBOT a crucial treatment option across many medical specialties. The UHMS consistently lists Air or Gas Embolism as the first indication in its "Hyperbaric Oxygen Therapy Indications," underscoring its established role. UHMS Hyperbaric Oxygen Therapy Indications for Air or Gas Embolism provides detailed context on this condition.

Clinical Manifestations and Treatment Efficacy

The clinical effects of gas embolism vary depending on the volume and location of the gas bubbles. Small volumes of air injected intra-arterially can cause clinical deficits. In contrast, intravenous injection is often asymptomatic. Experimental animals have tolerated intravenous injections of up to 0.5-1 mL/kg. In humans, a continuous intravenous infusion of oxygen at 10 mL/min has been reported as well tolerated, but 20 mL/min caused symptoms. Injections of air are generally more likely to cause clinical abnormalities compared to constant infusions.

For venous gas embolism (VGE), bubbles are commonly trapped by pulmonary capillaries and usually do not cause symptoms. However, large volumes of VGE can lead to cough, dyspnea, and pulmonary edema. If the pulmonary capillary network is overwhelmed, bubbles can enter the arterial circulation. VGE can also bypass the lungs and enter the left heart directly through an atrial septal defect or patent foramen ovale.

HBOT works by increasing the ambient pressure, which physically reduces the size of gas bubbles in the bloodstream, allowing them to pass through capillaries more easily or to be reabsorbed. Additionally, the high concentration of oxygen delivered under pressure helps to oxygenate tissues that may be deprived due to the embolism, mitigating damage. This dual mechanism makes HBOT the most effective treatment for gas embolism, leading to its consistent inclusion in UHMS guidelines and subsequent Medicare coverage. Clinics must document the specific type of gas embolism and its cause to support billing claims.

Documentation Requirements for Medicare

When billing Medicare for HBOT for gas embolism, rigorous documentation is essential. Clinics must provide clear evidence of the diagnosis, the acute nature of the condition, and the immediate need for hyperbaric intervention. This includes:

Detailed patient history and physical examination findings.
Results from imaging studies (e.g., CT scans, echocardiograms) that confirm the presence of gas embolism.
Documentation of the event leading to the gas embolism, whether it's a diving incident, a surgical complication, or another identified cause.
A clear treatment plan outlining the pressure, duration, and frequency of HBOT sessions, consistent with UHMS recommendations for gas embolism.

Without thorough and accurate documentation, even for a clearly indicated condition like gas embolism, Medicare claims are likely to be denied. This underscores the need for HBOT clinics to have robust internal processes for record-keeping and billing compliance.

Why Are UHMS Accreditation and FDA Recommendations Important?

UHMS accreditation and FDA recommendations are vitally important for hyperbaric oxygen therapy (HBOT) clinics because they establish standards of quality, safety, and efficacy. These endorsements provide a framework that assures both patients and payers, including Medicare, that a facility operates with integrity and provides care based on recognized medical evidence. Accreditation by the Undersea & Hyperbaric Medical Society (UHMS) signifies that a facility adheres to rigorous guidelines for equipment, personnel, and operational procedures, which are crucial for delivering safe and effective HBOT.

The FDA's recommendation for UHMS-accredited facilities for treating specific illnesses with HBOT further solidifies this importance. This statement from a federal regulatory agency highlights the critical role of accreditation in ensuring patient safety and the appropriate use of medical devices. When the FDA points to UHMS accreditation, it signals that these facilities are recognized as meeting high standards, which can influence Medicare's perception of a clinic's reliability and quality of care. This synergy between a medical society and a federal agency creates a strong foundation for trust and accountability in the hyperbaric medicine community.

The Value of UHMS Accreditation

UHMS accreditation is a voluntary process that hyperbaric facilities undertake to demonstrate their commitment to excellence. It involves a comprehensive review of a clinic's operations, including:

Equipment Safety: Ensuring that hyperbaric chambers, such as monoplace or multiplace chambers, meet safety standards and are properly maintained. Multiplace chambers can treat several patients at once and allow medical staff to be inside with patients, while monoplace chambers treat one patient at a time. The type of chamber used is critical for specific treatment protocols.
Staff Competency: Verifying that physicians, nurses, and technicians are adequately trained and certified in hyperbaric medicine. This includes knowledge of hyperbaric physiology, emergency procedures, and patient care protocols.
Clinical Protocols: Reviewing treatment plans and patient management strategies to ensure they align with UHMS-approved indications and best practices.
Emergency Preparedness: Assessing a facility's ability to handle potential complications and emergencies that may arise during HBOT.

Achieving UHMS accreditation is a testament to a facility's dedication to providing high-quality care. It tells patients that they are receiving treatment in an environment that prioritizes their safety and adheres to nationally recognized standards. For Medicare, accreditation can serve as an indicator of a clinic's credibility and its commitment to evidence-based medicine, potentially streamlining the billing and reimbursement process by reducing scrutiny. The UHMS Hyperbaric Facility Accreditation Program is designed to ensure these high standards are met.

FDA's Role and Recommendations

The U.S. Food & Drug Administration (FDA) is responsible for protecting public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices. While the FDA does not directly accredit HBOT facilities, its recommendation for UHMS-accredited facilities is significant. This recommendation essentially aligns the FDA's public health mission with the UHMS's efforts to set clinical standards.

This alignment means that when a clinic seeks Medicare reimbursement, having UHMS accreditation can implicitly address concerns about the quality and safety of the HBOT services provided. The FDA's focus on medical devices, including hyperbaric chambers, is well-documented. For instance, the 510(k) Premarket Notification process ensures that medical devices are safe and effective before they are marketed. A device like a hyperbaric chamber would undergo such a review, as seen with records like k021690. The FDA's recommendation for UHMS-accredited facilities for treating specific illnesses underscores the importance of proper oversight and adherence to established protocols in using these devices. FDA Recommendation for UHMS-Accredited Facilities clearly states this position.

Impact on Medicare Billing and Compliance

For Medicare billing, the importance of UHMS accreditation and FDA recommendations cannot be overstated. While not a direct requirement for Medicare reimbursement, these endorsements can significantly influence how claims are processed and perceived. Clinics that are accredited demonstrate a proactive approach to quality assurance, which can reduce the likelihood of audits and claim denials.

Medicare's scrutiny of HBOT claims often focuses on medical necessity and the quality of care provided. A UHMS-accredited facility can more easily demonstrate that its services meet high standards and are delivered by competent professionals using appropriate equipment. This can lead to smoother billing operations and greater financial stability for the clinic. Furthermore, in our experience, facilities that adhere to these standards are better positioned to adapt to any future changes in Medicare policies or requirements, as they already operate within a framework of best practices. Lindell K. Weaver MD, Chair and Editor of the 13th edition of the UHMS Indications, reminds us that "No responsibility is assumed by the Publisher or Editor for any injury and or damage to persons or property as a matter of product liability, negligence or otherwise, or from any use or operation of any methods, product, instructions, or ideas contained in the material herein. No suggested test or procedure should be carried out unless, in the reader’s judgment, its risk is justified. Because of rapid advances in the medical sciences, we recommend that the independent verification of diagnoses and drug dosages be made." This highlights the importance of professional judgment and adherence to guidelines in a rapidly evolving medical field.

Ensuring Patient Trust and Safety

Ultimately, UHMS accreditation and FDA recommendations are about patient trust and safety. Patients seeking HBOT want assurance that they are receiving care from qualified professionals in a safe environment. These endorsements provide that assurance, helping patients make informed decisions about their treatment options. For clinics, maintaining these standards is not just about compliance and billing; it's about upholding ethical responsibilities and delivering the best possible outcomes for patients. This commitment to excellence fosters a positive reputation and contributes to the overall advancement of hyperbaric medicine.

What Role Do Different Types of Hyperbaric Chambers Play in Billing?

The type of hyperbaric chamber used in a clinic can influence various aspects of treatment delivery, patient experience, and operational logistics, but Medicare coverage primarily focuses on the medical necessity of the treatment itself, rather than the specific chamber type. While the chamber type might dictate aspects like the number of patients treated simultaneously or the presence of medical staff inside the chamber, Medicare reimbursement decisions hinge on whether the patient's condition aligns with a UHMS-approved indication and if the treatment protocol is medically appropriate for that indication.

Hyperbaric chambers generally fall into two main categories: monoplace and multiplace chambers. Monoplace chambers are designed to treat a single patient at a time, often with the patient lying down in a clear acrylic cylinder. The entire chamber is pressurized with 100% oxygen. Multiplace chambers, on the other hand, are larger rooms or cylindrical structures that can treat multiple patients simultaneously. These chambers are typically pressurized with compressed air, and patients breathe 100% oxygen through hoods or masks. The choice between these types impacts clinic flow and staffing but usually not the fundamental eligibility for Medicare coverage, provided the treatment parameters (pressure, duration, oxygen concentration) meet the UHMS guidelines for the specific indication.

Monoplace Chambers and Their Impact

Monoplace chambers offer a private, individualized treatment experience. The patient lies in a chamber that is then sealed and pressurized with pure oxygen. This direct delivery of 100% oxygen simplifies the setup for oxygen administration, as the entire environment is oxygen-rich.

From a billing perspective, the use of a monoplace chamber does not inherently alter the Medicare reimbursement rates for HBOT. The Current Procedural Terminology (CPT) codes for hyperbaric oxygen therapy typically cover the treatment session itself, regardless of whether it occurs in a monoplace or multiplace setting. The focus remains on the medical necessity of the HBOT for an approved condition, such as central retinal artery occlusion or refractory osteomyelitis. The documentation must clearly show that the patient meets the criteria for one of the 14 UHMS-approved indications. Factors such as the prescribed pressure, the duration of the treatment, and the total number of sessions are more relevant to the clinical efficacy and therefore the justification for billing than the specific chamber type.

Multiplace Chambers and Their Implications

Multiplace chambers allow for the treatment of several patients at once, and medical staff can remain inside the chamber with the patients during treatment. This setup can be advantageous for critically ill patients who require continuous monitoring or hands-on medical intervention during the hyperbaric session. In a multiplace chamber, the environment is pressurized with compressed air, and patients receive 100% oxygen through a mask or hood system.

Similar to monoplace chambers, the use of a multiplace chamber does not change the core Medicare billing requirements. The clinic still needs to demonstrate that the HBOT is medically necessary for a UHMS-approved indication. However, multiplace chambers might allow for greater flexibility in managing patient loads and coordinating care for multiple patients simultaneously, which can have operational and cost-efficiency benefits for the clinic. These operational benefits, while important for clinic management, are distinct from the criteria Medicare uses to determine coverage for individual patient treatments. For example, treating conditions like severe anemia or adjunctive HBOT for thermal burns may involve patients who benefit from having medical staff present inside the chamber, which is facilitated by a multiplace setup. See the severe anemia evidence atlas for the full study-by-study evidence breakdown.

Billing Codes and Medical Necessity

Regardless of the chamber type, the billing codes for HBOT are generally standardized. The primary CPT code for HBOT typically represents a treatment session. The critical factor for Medicare reimbursement is the proper application of these codes in conjunction with the correct diagnosis codes (ICD-10 codes) that correspond to the UHMS-approved indications.

Medicare's review process will focus on whether the documentation supports the medical necessity of the HBOT. This includes:

Diagnosis: The patient's primary diagnosis must be one of the UHMS-approved indications.
Documentation of Need: The medical record must clearly articulate why HBOT is necessary for the patient's condition, including any prior failed treatments if applicable (e.g., for problem wounds or refractory osteomyelitis).
Treatment Protocol: The prescribed pressure, duration, and frequency of HBOT sessions must align with established clinical guidelines for the specific indication.

The Undersea and Hyperbaric Medical Society's "Hyperbaric Oxygen Therapy Indications" (14th Edition) serves as the definitive guide for these protocols. Clinics must ensure that their documentation for each patient clearly links the HBOT treatment to an approved indication and adheres to the recommended parameters, irrespective of whether a monoplace or multiplace chamber is utilized.

Operational Considerations vs. Reimbursement Criteria

While the choice of chamber type largely impacts a clinic's operational model—such as staffing requirements, patient throughput, and the ability to manage emergencies—these operational considerations are separate from Medicare's reimbursement criteria. Medicare is primarily concerned with the clinical appropriateness and effectiveness of the therapy for the patient's condition.

For instance, a clinic might choose a multiplace chamber to accommodate more patients or to facilitate the treatment of complex cases requiring continuous medical presence. While these are valid operational decisions, they do not directly dictate whether a specific patient's HBOT session will be covered by Medicare. The underlying medical condition and its alignment with UHMS indications remain the paramount factors for billing success. Therefore, clinics should prioritize adherence to UHMS guidelines and meticulous documentation of medical necessity above all else when planning their billing strategies.

Frequently Asked Questions

Is HBOT covered by Medicare for all conditions?

No, HBOT is not covered by Medicare for all conditions. Medicare generally covers Hyperbaric Oxygen Therapy only for specific medical conditions that are recognized as medically necessary by authoritative bodies like the Undersea & Hyperbaric Medical Society (UHMS). The UHMS has published its "Hyperbaric Oxygen Therapy Indications" in a 14th edition, which lists 14 primary approved conditions for HBOT. Treatments for conditions not on this list are typically not reimbursed by Medicare.

What is the Undersea & Hyperbaric Medical Society (UHMS)?

The Undersea & Hyperbaric Medical Society (UHMS) is a non-profit organization that serves as a leading authority in undersea and hyperbaric medicine. It develops and publishes comprehensive guidelines, such as the "Hyperbaric Oxygen Therapy Indications," which detail the approved medical conditions for HBOT. The UHMS, located at 631 US Highway 1, Suite 307, North Palm Beach, FL 33408, USA, also offers accreditation for hyperbaric facilities, signaling adherence to high standards of care and safety.

Does Medicare require UHMS accreditation for HBOT clinics?

Medicare does not explicitly require UHMS accreditation for HBOT clinics to receive reimbursement. However, the FDA recommends UHMS-accredited hyperbaric facilities for treating specific illnesses, which indirectly underscores the value of accreditation. UHMS accreditation signifies that a clinic meets high standards for equipment, staff competency, and clinical protocols, which can enhance a clinic's credibility and potentially streamline the Medicare billing process due to demonstrated quality and compliance.

Can HBOT be used for conditions not on the UHMS approved list?

While HBOT might be used for conditions not on the UHMS approved list in some contexts (e.g., investigational studies), Medicare will generally not cover these treatments. Medicare coverage is tied to medical necessity, which is largely defined by the UHMS-approved indications. Treating conditions outside this list means that clinics are unlikely to receive reimbursement from Medicare, and patients would typically be responsible for the full cost of therapy.

How often can a patient receive HBOT under Medicare?

The frequency and total number of HBOT sessions covered by Medicare depend on the specific UHMS-approved indication and the patient's clinical response. For example, gas embolism can occur from pulmonary barotrauma after an ascent of as little as one meter, and treatment protocols for such acute conditions may involve intensive initial therapy. Each indication has recommended treatment protocols, including typical durations and frequencies, which clinics must follow and document to ensure Medicare coverage.